Literature DB >> 1431713

Contributions of incidence and case fatality to mortality from bladder cancer in the south Thames Regions.

A Walker1, A Petruckevitch, H Bourne, P Burney.   

Abstract

STUDY
OBJECTIVE: The aim was to assess the individual contributions of incidence and case fatality to variations in bladder cancer mortality between districts in the South Thames Regions.
DESIGN: The standardised mortality ratios for bladder cancer were calculated for the health districts in the South Thames Regions using data from the Thames Cancer Registry. The results were compared with the standardised registration ratios, used as a measurement of incidence, and survival hazard function, used as a measurement of case fatality. As one determinant of case fatality is the severity at presentation, mortality was also compared with the standardised proportion of cases with advanced disease at diagnosis.
SETTING: The study took place in the 28 health districts in South East and South West Thames regional health authorities.
SUBJECTS: Subjects were 3271 cases of bladder cancer aged 15-74 years resident in one of the two South Thames regional health authorities at diagnosis and registered between 1982 and 1985. MAIN
RESULTS: The standardised mortality ratios for the different districts varied from 62 to 139. The standardised registration ratios, the survival hazard functions adjusted for age and stage of disease at diagnosis, and the proportion of cases with severe disease at diagnosis were all independently and significantly related to the standardised mortality ratios in each district.
CONCLUSIONS: Mortality from bladder cancer was significantly related to measurements of incidence, case fatality, and severity at presentation. These relations have implications for the health services. The incidence of disease may be modified through preventative measures, the case fatality through improved quality of care, and severity at presentation possibly through prompt management of patients with haematuria. Further studies are needed to investigate why these factors have high values in some districts.

Entities:  

Mesh:

Year:  1992        PMID: 1431713      PMCID: PMC1059606          DOI: 10.1136/jech.46.4.387

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  10 in total

1.  DELAY IN TREATING BLADDER TUMOURS.

Authors:  D M WALLACE; D L HARRIS
Journal:  Lancet       Date:  1965-08-14       Impact factor: 79.321

Review 2.  Biology and management of bladder cancer.

Authors:  D Raghavan; W U Shipley; M B Garnick; P J Russell; J P Richie
Journal:  N Engl J Med       Date:  1990-04-19       Impact factor: 91.245

3.  Measuring the quality of medical care. A clinical method.

Authors:  D D Rutstein; W Berenberg; T C Chalmers; C G Child; A P Fishman; E B Perrin
Journal:  N Engl J Med       Date:  1976-03-11       Impact factor: 91.245

4.  Smoking and cancer of the lower urinary tract.

Authors:  P Cole; R R Monson; H Haning; G H Friedell
Journal:  N Engl J Med       Date:  1971-01-21       Impact factor: 91.245

5.  Geographical variation in mortality from conditions amenable to medical intervention in England and Wales.

Authors:  J R Charlton; R M Hartley; R Silver; W W Holland
Journal:  Lancet       Date:  1983-03-26       Impact factor: 79.321

6.  Delays in diagnosing and treating bladder cancer.

Authors:  M J Stower
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-30

Review 7.  Occupational urothelial cancer.

Authors:  D M Wallace
Journal:  Br J Urol       Date:  1988-03

8.  Survival of transitional cell carcinoma cases in 2 Yorkshire centres.

Authors:  R A Cartwright; R W Glashan; B Gray
Journal:  Br J Urol       Date:  1980-12

9.  Bladder cancer: factors affecting survival.

Authors:  A S Narayana; S A Loening; D J Slymen; D A Culp
Journal:  J Urol       Date:  1983-07       Impact factor: 7.450

10.  Treatment delay in patients with bladder tumours.

Authors:  C MacArthur; L L Pendleton; A Smith
Journal:  J Epidemiol Community Health       Date:  1985-03       Impact factor: 3.710

  10 in total
  2 in total

1.  Studies of avoidable factors influencing death: a call for explicit criteria.

Authors:  R Westerling
Journal:  Qual Health Care       Date:  1996-09

2.  Components of small area variation in death rates: a method applied to data from Sweden.

Authors:  R Westerling
Journal:  J Epidemiol Community Health       Date:  1995-04       Impact factor: 3.710

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.